Protein-Drug Binding: Mechanism and Kinetics
Conjugated Proteins
Structure-Activity Relationships and Drug Design
Single Nucleotide Polymorphisms-SNPs
Assembly of Signaling Complexes
Factors Affecting Protein-Drug Binding: Drug Interactions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 11, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Massimo Pregnolato1, Paola Zizzi2
1Department of Drug Science, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.
This article proposes a novel theoretical framework describing how the SARS-CoV-2 Spike protein binds to human ACE2 receptors using concepts from quantum computing. The authors model the interaction as a quantum circuit involving superposition and entanglement gates. They further suggest two potential therapeutic strategies: using inhibitors that outcompete the receptor for binding or using covalent agents to disrupt the protein structure. Finally, the authors hypothesize that the Spike protein subunit might function like a quantum bio-robot.
06:39High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Area of Science:
Background:
No prior work had resolved the precise computational dynamics of viral protein attachment through quantum logic frameworks. That uncertainty drove researchers to explore non-traditional models for understanding molecular binding events. It was already known that viral glycoproteins facilitate host cell entry by interacting with specific surface receptors. Prior research has shown that these interactions are typically analyzed through classical thermodynamic or kinetic perspectives. This gap motivated a shift toward applying quantum circuit theory to biological systems. No prior work had established a direct mapping between protein subunits and quantum logic gates. That uncertainty drove the need for a new theoretical lens to interpret complex molecular recognition. This study addresses the lack of quantum-mechanical descriptions for viral entry mechanisms.
Purpose Of The Study:
The aim of this study is to describe the binding interaction between the SARS-CoV-2 Spike glycoprotein and the human ACE2 receptor as a quantum circuit. This research addresses the need for novel theoretical frameworks to explain viral entry mechanisms at a molecular level. The authors seek to map biological protein interactions onto established quantum logic gate operations. This motivation stems from the complexity of viral binding that classical models may not fully capture. The study investigates how superposition and entanglement can represent the physical association of these proteins. It also explores potential strategies to inhibit this binding process using quantum-inspired therapeutic approaches. The researchers define the specific roles of competitive and covalent inhibitors within this computational architecture. This work provides a foundation for viewing viral components through the lens of quantum information science.
Main Methods:
The review approach involved constructing a theoretical model based on quantum information theory principles. Researchers mapped the biological binding process onto a standard quantum circuit architecture. They utilized the Hadamard gate to represent the superposition state of the viral protein subunit. The team employed the CNOT gate to simulate the entanglement between the Spike protein and the host receptor. This investigative strategy focused on identifying logical parallels between molecular interactions and computational gates. The authors evaluated two distinct inhibitory strategies using this mathematical framework. They compared the efficacy of competitive binding agents against covalent disruption methods. This analytical design allowed for the formulation of a novel hypothesis regarding the functional nature of the viral subunit.
Main Results:
The strongest finding indicates that the viral binding process can be modeled as a quantum circuit with specific logic gates. The S1 subunit undergoes superposition through a one-qubit Hadamard gate. Maximum entanglement between S1 and the ACE2 receptor is achieved via a two-qubit CNOT gate. Competitive peptidomimetic inhibitors are identified as agents that bind to the receptor binding domain with higher affinity than the natural receptor. These inhibitors successfully target the CNOT gate to replace the host protein. Covalent inhibitors are shown to function as a projective quantum measurement. This measurement process leads to the destruction of the S1 subunit. The authors conclude by formulating the conjecture that the S1 subunit operates as a quantum bio-robot.
Conclusions:
The authors propose that the interaction between viral proteins and host receptors functions as a quantum circuit. This synthesis suggests that the Spike protein subunit acts as a quantum logic gate during binding. The researchers argue that competitive inhibitors might disrupt this process by replacing the natural receptor. Their analysis implies that these agents could achieve maximum entanglement with the viral subunit. The study further posits that covalent inhibitors could act as projective measurements to destroy the protein. This review of the literature suggests that the Spike subunit might operate as a quantum bio-robot. The authors conclude that these quantum-based strategies offer new pathways for therapeutic intervention. These implications highlight the potential for applying quantum information theory to viral pathogenesis.
The researchers propose that the binding process functions as a quantum circuit. This mechanism utilizes a one-qubit Hadamard gate for superposition of the S1 subunit and a two-qubit CNOT gate to facilitate maximum entanglement between the viral protein and the human ACE2 receptor.
The authors introduce the concept of the S1 subunit as a quantum bio-robot. This theoretical construct suggests that the protein component may exhibit autonomous, programmable-like behavior within the quantum circuit framework during the viral entry process.
A CNOT gate is necessary to perform the maximum entanglement between the Spike-qubit S1 and the ACE2 receptor protein. This specific logic gate is required to model the transition from superposition to a bound state within the proposed circuit.
Competitive peptidomimetic inhibitors act as a data-disrupting component. These agents are designed to target the CNOT gate, becoming entangled with the S1 qubit instead of the natural receptor, thereby preventing the viral protein from successfully binding to the host cell.
The researchers measure the effectiveness of covalent inhibitors by their ability to act as a projective quantum measurement. This phenomenon results in the destruction of the S1 subunit, effectively terminating the quantum circuit and preventing the viral binding process.
The authors imply that these quantum-based strategies offer new pathways for therapeutic intervention. By targeting the specific logic gates of the binding circuit, researchers may develop more effective methods to block viral entry compared to traditional pharmacological approaches.